Jonathan P. Schneck

11.5k total citations · 1 hit paper
139 papers, 7.3k citations indexed

About

Jonathan P. Schneck is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jonathan P. Schneck has authored 139 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Immunology, 57 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Jonathan P. Schneck's work include Immunotherapy and Immune Responses (78 papers), Immune Cell Function and Interaction (70 papers) and T-cell and B-cell Immunology (56 papers). Jonathan P. Schneck is often cited by papers focused on Immunotherapy and Immune Responses (78 papers), Immune Cell Function and Interaction (70 papers) and T-cell and B-cell Immunology (56 papers). Jonathan P. Schneck collaborates with scholars based in United States, Germany and Ukraine. Jonathan P. Schneck's co-authors include Mathias Oelke, Karlo Perica, Joan Glick Bieler, Michael Edidin, Tarek M. Fahmy, Drew M. Pardoll, Jordan J. Green, Kapil Gupta, Alyssa K. Kosmides and Dmitry I. Gabrilovich and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Jonathan P. Schneck

135 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

2007 889 citations Srinivas Nagaraj, Kapil Gupta et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan P. Schneck United States	43	5.4k	2.5k	1.9k	929	670	139	7.3k
Lélia Delamarre United States	28	3.9k 0.7×	1.5k 0.6×	2.0k 1.0×	269 0.3×	379 0.6×	50	5.4k
Peter Van Endert France	55	8.4k 1.6×	3.7k 1.5×	4.6k 2.4×	828 0.9×	705 1.1×	171	13.6k
Gerd Ritter United States	62	9.2k 1.7×	5.4k 2.2×	5.6k 3.0×	445 0.5×	1.8k 2.7×	182	14.2k
Charles L. Sentman United States	46	5.3k 1.0×	3.3k 1.3×	1.8k 1.0×	781 0.8×	412 0.6×	115	7.6k
Yutaka Tagaya United States	37	5.2k 1.0×	1.8k 0.7×	951 0.5×	172 0.2×	196 0.3×	96	6.5k
Tania H. Watts Canada	55	6.9k 1.3×	2.2k 0.9×	2.2k 1.2×	245 0.3×	612 0.9×	146	9.6k
Hugues Lortat‐Jacob France	53	2.1k 0.4×	1.3k 0.5×	3.8k 2.0×	287 0.3×	490 0.7×	146	8.1k
Ellen S. Vitetta United States	58	6.9k 1.3×	1.9k 0.8×	3.7k 2.0×	517 0.6×	3.3k 5.0×	250	11.4k
Ferry Ossendorp Netherlands	64	9.3k 1.7×	3.8k 1.5×	5.2k 2.8×	1.7k 1.9×	1.0k 1.6×	228	13.7k
J. Thomas August United States	46	2.5k 0.5×	650 0.3×	4.1k 2.2×	281 0.3×	655 1.0×	106	7.8k

Countries citing papers authored by Jonathan P. Schneck

Since Specialization

Citations

This map shows the geographic impact of Jonathan P. Schneck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan P. Schneck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan P. Schneck more than expected).

Fields of papers citing papers by Jonathan P. Schneck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan P. Schneck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan P. Schneck. The network helps show where Jonathan P. Schneck may publish in the future.

Co-authorship network of co-authors of Jonathan P. Schneck

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan P. Schneck. A scholar is included among the top collaborators of Jonathan P. Schneck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan P. Schneck. Jonathan P. Schneck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neshat, Sarah Y., et al.. (2026). Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion. Science Advances. 12(11). eadz1722–eadz1722.

Est‐Witte, Savannah, Shuyi Li, Sarah Y. Neshat, et al.. (2024). Alginate-based artificial antigen presenting cells expand functional CD8+ T cells with memory characteristics for adoptive cell therapy. Biomaterials. 313. 122773–122773. 6 indexed citations

Schneck, Jonathan P., et al.. (2024). Nanoparticle Targeting Strategies for Lipid and Polymer‐Based Gene Delivery to Immune Cells In Vivo. SHILAP Revista de lepidopterología. 4(9). 2400248–2400248. 16 indexed citations

Ben‐Akiva, Elana, John W. Hickey, Randall A. Meyer, et al.. (2023). Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy. Acta Biomaterialia. 160. 187–197. 25 indexed citations

Wang, Hanzhi, Theodore Kouo, Sebastian F. Salathe, et al.. (2022). Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2. JCI Insight. 7(18). 10 indexed citations

Isser, Ariel, Hawley C. Pruitt, Niklas Bachmann, et al.. (2022). Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy. Nature Communications. 13(1). 6086–6086. 17 indexed citations

Rhodes, Kelly R., Ariel Isser, John W. Hickey, et al.. (2021). Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma. ACS Applied Materials & Interfaces. 13(7). 7913–7923. 26 indexed citations

Est‐Witte, Savannah, et al.. (2021). Nanoparticles for generating antigen-specific T cells for immunotherapy. Seminars in Immunology. 56. 101541–101541. 24 indexed citations

Ichikawa, Junya, Tatsuya Yoshida, Ariel Isser, et al.. (2020). Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells. Clinical Cancer Research. 26(13). 3384–3396. 34 indexed citations

10.

Sidhom, John-William, Catherine Bessell, Jonathan J. Havel, et al.. (2017). ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis. Cancer Immunology Research. 6(2). 151–162. 31 indexed citations

11.

Rudqvist, Nils-Petter, Karsten A. Pilones, Claire Lhuillier, et al.. (2017). Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells. Cancer Immunology Research. 6(2). 139–150. 163 indexed citations

12.

Temkin, Sarah M., Sarah Spiegel, Simeon E. Goldblum, et al.. (2016). VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells. Clinical Cancer Research. 22(16). 4249–4258. 30 indexed citations

13.

Bruns, Heiko, Catherine Bessell, Juan Carlos Varela, et al.. (2015). CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells. Clinical Cancer Research. 21(9). 2075–2083. 21 indexed citations

14.

Webb, Tonya J., Xiangming Li, Robert Giuntoli, et al.. (2012). Molecular Identification of GD3 as a Suppressor of the Innate Immune Response in Ovarian Cancer. Cancer Research. 72(15). 3744–3752. 74 indexed citations

15.

Xiao, Zuoxiang, Andrew Marshall, Hiroaki Kimura, et al.. (2011). Inhibition of Fas Ligand in NOD Mice Unmasks a Protective Role for IL-10 against Insulitis Development. American Journal Of Pathology. 179(2). 725–732. 24 indexed citations

16.

Ugel, Stefano, Alessia Zoso, Carmela De Santo, et al.. (2009). In vivo Administration of Artificial Antigen-Presenting Cells Activates Low-Avidity T Cells for Treatment of Cancer. Cancer Research. 69(24). 9376–9384. 56 indexed citations

17.

Nagaraj, Srinivas, Kapil Gupta, В. М. Писарев, et al.. (2007). Altered recognition of antigen is a novel mechanism of CD8+ T cell tolerance in cancer. Cancer Research. 67. 1587–1587. 2 indexed citations

18.

Hamad, Abdel Rahim A., et al.. (2003). B220+ Double-Negative T Cells Suppress Polyclonal T Cell Activation by a Fas-Independent Mechanism That Involves Inhibition of IL-2 Production. The Journal of Immunology. 171(5). 2421–2426. 40 indexed citations

19.

O’Herrin, Sean M., Jill E. Slansky, Qizhi Tang, et al.. (2001). Antigen-Specific Blockade of T Cells In Vivo Using Dimeric MHC Peptide. The Journal of Immunology. 167(5). 2555–2560. 50 indexed citations

20.

Hamad, Abdel Rahim A., Paria Mirmonsef, Chris P. M. Broeren, et al.. (2001). Lack of Coreceptor Allows Survival of Chronically Stimulated Double-Negative α/β T Cells. The Journal of Experimental Medicine. 193(10). 1113–1122. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact